A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases

MP Perisa, MJ Rose, E Varga… - Pediatric Blood & …, 2019 - Wiley Online Library
MP Perisa, MJ Rose, E Varga, MK Kamboj, JD Spencer, RPS Bajwa
Pediatric Blood & Cancer, 2019Wiley Online Library
We present here a case of MIRAGE syndrome due to novel variant (c. 2318T> C) in the
sterile α motif domain‐containing protein 9 (SAMD9) gene. Previous reports have described
the clinical phenotype, which includes myelodysplasia, recurrent infections, restriction of
growth and development, adrenal insufficiency, genitourinary abnormalities, and
enteropathies, often resulting in fatality within the first few years of life. This report illustrates
the variability in phenotype by describing an 11‐year‐old male, diagnosed with MIRAGE at …
Abstract
We present here a case of MIRAGE syndrome due to novel variant (c.2318T>C) in the sterile α motif domain‐containing protein 9 (SAMD9) gene. Previous reports have described the clinical phenotype, which includes myelodysplasia, recurrent infections, restriction of growth and development, adrenal insufficiency, genitourinary abnormalities, and enteropathies, often resulting in fatality within the first few years of life. This report illustrates the variability in phenotype by describing an 11‐year‐old male, diagnosed with MIRAGE at age 9 years when his novel variant was identified through whole exome sequencing. A brief review of previously published cases of MIRAGE syndrome and the genotypic and phenotypic spectrum are presented.
Wiley Online Library